Voloridge Investment Management LLC Lowers Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Voloridge Investment Management LLC lessened its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 19.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 783,690 shares of the company's stock after selling 186,075 shares during the quarter. Voloridge Investment Management LLC owned 0.38% of Cellebrite DI worth $17,265,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in Cellebrite DI in the 4th quarter valued at $9,995,000. Teacher Retirement System of Texas bought a new position in Cellebrite DI in the 4th quarter valued at $442,000. New York State Common Retirement Fund grew its stake in Cellebrite DI by 2.6% in the 4th quarter. New York State Common Retirement Fund now owns 189,599 shares of the company's stock valued at $4,177,000 after purchasing an additional 4,838 shares during the period. SG Americas Securities LLC grew its stake in Cellebrite DI by 2,244.2% in the 4th quarter. SG Americas Securities LLC now owns 209,529 shares of the company's stock valued at $4,616,000 after purchasing an additional 200,591 shares during the period. Finally, Pembroke Management LTD grew its stake in Cellebrite DI by 4.4% in the 4th quarter. Pembroke Management LTD now owns 1,992,432 shares of the company's stock valued at $43,893,000 after purchasing an additional 84,087 shares during the period. Institutional investors own 45.88% of the company's stock.

Cellebrite DI Stock Performance

NASDAQ CLBT traded up $0.50 during trading hours on Friday, hitting $17.21. The company had a trading volume of 1,554,679 shares, compared to its average volume of 1,462,127. Cellebrite DI Ltd. has a 52 week low of $10.25 and a 52 week high of $26.30. The firm has a 50 day simple moving average of $18.91 and a 200 day simple moving average of $20.19. The firm has a market capitalization of $4.12 billion, a price-to-earnings ratio of -12.38, a PEG ratio of 4.27 and a beta of 1.44.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last issued its earnings results on Wednesday, May 14th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. The business had revenue of $107.55 million during the quarter, compared to the consensus estimate of $109.36 million. During the same quarter last year, the company earned $0.08 EPS. The firm's revenue was up 20.0% compared to the same quarter last year. On average, research analysts forecast that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

Analyst Ratings Changes

CLBT has been the subject of a number of recent analyst reports. Needham & Company LLC reduced their price objective on Cellebrite DI from $28.00 to $24.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. Lake Street Capital increased their price target on Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a research note on Friday, February 14th. Finally, JPMorgan Chase & Co. cut their price target on Cellebrite DI from $29.00 to $25.00 and set an "overweight" rating for the company in a research note on Monday, May 12th. Seven research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $22.43.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.